{
    "2020-05-06": [
        [
            {
                "time": "",
                "original_text": "【华泰医药代雯团队】医药行业20年一季报总结：刚需属性凸显，内部分化加剧",
                "features": {
                    "keywords": [
                        "医药行业",
                        "一季报",
                        "刚需属性",
                        "内部分化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【兴业证券医药】行业比较优势突出，细分领域分化明显 — 医药生物上市公司2019年报及2020年一季报小结",
                "features": {
                    "keywords": [
                        "医药生物",
                        "年报",
                        "一季报",
                        "行业比较优势",
                        "细分领域分化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}